Low-vision rehabilitation in Italy: Cross-sectional data from the Device and Aids Registry (D.A.Re).

Retina age-related macular degeneration genetics glaucoma optics/refraction/instruments retina retinal pathology/research

Journal

European journal of ophthalmology
ISSN: 1724-6016
Titre abrégé: Eur J Ophthalmol
Pays: United States
ID NLM: 9110772

Informations de publication

Date de publication:
Jul 2022
Historique:
pubmed: 5 4 2022
medline: 22 7 2022
entrez: 4 4 2022
Statut: ppublish

Résumé

We are reporting on the characteristics of low-vision adults attending large rehabilitation services which provide data to D.A.Re (Devices & Aids REgister) in Italy. D.A.Re aims to gather information about low-vision aids owned by Italian patients with visual impairment. We included consecutive patients attending low-vision rehabilitation centres providing data to D.A.Re from 2019 to July 2021. Demographic features, self-reported use of technology and aids, vision performance, and the Instrumental Activity of Daily Living (IADL) score were collected. 720 patients were included in the D.A.Re. About half of the patients were affected by Age-related Macular Degeneration (389, 54.9%). Patients reported a long interval between onset of vision disability and access to low-vision rehabilitation, which was over two years in almost 30% of cases. Blindness registration status was almost complete when reported, but almost 40% were unable to report on this. IADL scores were higher for younger people and those with better visual acuity and critical print size (CPS), and lower for visual field restriction ( We report on the profile of low-vision patients using rehabilitation services in Italy. Longitudinal data during and after vision rehabilitation were collected. Our results support the validity of the D.A.Re to monitor the use of low-vision devices in Italy.

Identifiants

pubmed: 35369783
doi: 10.1177/11206721221091367
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1942-1946

Auteurs

Federico Bartolomei (F)

Istituto Cavazza, Bologna, Italy.

Ilaria Biagini (I)

Department of Neurosciences, Psychology, Drug Research and Child Health (NEUROFARBA), University of Florence and AOU Careggi, Firenze, Italy.

Giovanni Sato (G)

Centro Oculistico S. Paolo Hospital, S. Antonio Padova, Italy.

Elisabetta Falchini (E)

Centro integrato per la Riabilitazione Visiva 'Carlo Monti', AOU Careggi, Firenze, Italy.

Alessia Di Simone (A)

C.E.R.Vi UICI, Enna, Italy.

Chiara Mastrantuono (C)

Centro Officina dei Sensi, Ascoli Piceno, Italy.

Silvia Micarelli (S)

Azienda Servizi alla Persona disabile visiva S. Alessio - Margherita di Savoia, Rome, Italy.

Gianni Virgili (G)

Department of Neurosciences, Psychology, Drug Research and Child Health (NEUROFARBA), University of Florence and AOU Careggi, Firenze, Italy.
Centre for Public Health, Queen's University of Belfast, Belfast, Northern Ireland (UK).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH